盐酸可乐定

盐酸可乐定 基本信息
CAS号 4205-91-8 分子式 C9H10Cl3N3
分子量 266.55500 精确质量  264.99400
PSA  36.42000 LogP  3.00390

基本信息 展开↓

CAS号:
4205-91-8
3D弹球模型:
立即前往扯扯看
分子式:
C9H10Cl3N3
分子量:
266.55500
中文名称:
盐酸可乐定
英文名称:
Clonidine hydrochloride
中文别名:
盐酸可乐定;
可乐亭;
2-(2,6-二氯苯胺)-2-咪唑啉盐酸盐;
[2-(2,6-二氯苯基)亚氨基]咪唑烷盐酸盐;
110降压片;
催压降;
2-(2,6-二氯苯胺基)-2-咪唑啉盐酸盐
英文别名:
Clonidine hydrochloride;
catapresan;
Neuclon;
clonidine HCl;
Clonidine (hydrochloride);
Clonidine HCl;
(2,6-dichloro-phenyl)-imidazolidin-2-ylidene-amine,hydrogen chloride;
(2,6-dichlorophenyl)imidazolidin-2-ylidene-amine hydrochloride;
klophelin;
clofelin;
atensina;
clonidine hydrochloride salt;
2-(2,6-Dichloroanilino)-2-iMidazoline Hydrochloride;
haemiton;
capresin;
dcai;
Clonidine Hydrochloride;
2-(2,6-Dichlorophenylamino)-2-imidazoline Hydrochloride;
DIXARIT;
hemiton
精确分子量/精确质量:
264.99400
极性分子表面积/PSA:
36.42000
油水分配系数/LogP:

LogP值指的是某物质在正辛醇/水两相体系中的分配系数的对数值,反映了物质在油水两相中的分配情况。其中、LogP值越大,说明该物质越亲油;反之,LogP值越小,则说明该物质越亲水。
贝尔斯坦号/MDL:
MFCD00036705
EINECS:
224-121-5
PubChem:
24277750
BRN:
4163525
InChI:
InChI=1/C9H9Cl2N3.ClH/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9;/h1-4,9,13-14H,5H2;1H

生产制备方法及用途展开↓

制备方法


由2,6-二氯苯胺经甲酰化、氯化、环合而得。将所得可乐定与无水乙醇及活性炭一起搅拌,加热回流,滤除活性炭,滤液加入氯化氢乙醇溶液中成盐,冷却结晶,过滤,用无水乙醇洗结晶,干燥,得可乐定盐酸盐。

合成制备方法


2,6-二氯苯胺经甲酰化、氯化、环合而得。将所得可乐定与无水乙醇及活性炭一起搅拌,加热回流,滤除活性炭,滤液加入氯化氢乙醇溶液中成盐,冷却结晶,过滤,用无水乙醇洗结晶,干燥,得可乐定盐酸盐。

用途简介


适应症1.高血压(不作为第一线用药)2.高血压急症。3.偏头痛、绝经期潮热、痛经。

用途


抗高血压和戒烟戒毒药。

物化性质展开↓

熔点:
312 °C
沸点:
319.3ºC at760mmHg
闪点:
146.9ºC
存储条件/存储方法:

避光,通风干燥处,密封保存

稳定性相关:

常温常压下稳定,白色结晶状粉末,溶于水、乙醇,几乎不溶于氯仿、乙醚

其它信息:

1.       性状:白色结晶性粉末

2.       密度(g/mL ,25/4):不确定

3.       相对蒸汽密度(,空气=1):不确定

4.       熔点(ºC):305

5.       沸点(ºC, 21mmHg):不确定

6.       沸点(ºC, 3mmHg):不确定

7.       折射率:不确定

8.       闪点(ºC):不确定

9.       比旋光度(º):不确定

10.    自燃点或引燃温度(ºC):不确定

11.    蒸气压(mmHg,25ºC):不确定

12.    饱和蒸气压(kPa,60ºC):不确定

13.    燃烧热(KJ/mol):不确定

14.    临界温度(ºC):不确定

15.    临界压力(KPa):不确定

16.    油水(辛醇/水)分配系数的对数值:不确定

17.    爆炸上限(%,V/V):不确定

18.    爆炸下限(%,V/V):不确定
19.水溶解性:溶于水、乙醇,几乎不溶于氯仿、乙醚

安全信息展开↓

包装等级:
III
风险类别:
6.1(b)
海关代码:
2933290090
WGK_Germany:
3
德国有关水污染物质的分类清单
危险类别码:
R25;R26
安全说明:
S22-S26-S28-S36/37/39-S45
RTECS号:
NJ2490000
安全标志:
S22:不要吸入粉尘。
S26:万一接触眼睛,立即使用大量清水冲洗并送医诊治。
S28:接触皮肤之后,立即使用大量皂液洗涤。
S45:出现意外或者感到不适,立刻到医生那里寻求帮助(最好带去产品容器标签)。
:
危险标志:
T+:Verytoxic;

合成路线查看所有的合成路线

  • 120-93-4

    2-咪唑烷酮

  • +

  • 60-80-0

    安替比林

  • +

  • 103-80-0

    氯化苯乙酰

  • 4205-91-8

    盐酸可乐定

  • 825-43-4

    2-oxo-imidazolidine-1-carboxylic acid ethyl ester

  • +

  • 608-31-1

    2,6-二氯苯胺

  • 4205-91-8

    盐酸可乐定

  • 5391-39-9

    N-乙酰基-2-咪唑烷酮

  • +

  • 608-31-1

    2,6-二氯苯胺

  • 4205-91-8

    盐酸可乐定

化学图谱

  1. 可乐定盐酸盐核磁图(1HNMR)

  2. 可乐定盐酸盐Raman光谱

  3. 可乐定盐酸盐核磁图(13CNMR)

  4. 可乐定盐酸盐质谱(MS)

  5. 可乐定盐酸盐红外图谱(IR1)

  6. 可乐定盐酸盐红外图谱(IR2)

上一页 1/4 下一页

毒理性展开↓

CHEMICAL IDENTIFICATION

RTECS NUMBER :
NJ2490000
CHEMICAL NAME :
2-Imidazoline, 2-(2,6-dichloroanilino)-, monohydrochloride
CAS REGISTRY NUMBER :
4205-91-8
LAST UPDATED :
199504
DATA ITEMS CITED :
28
MOLECULAR FORMULA :
C9-H9-Cl2-N3.Cl-H
MOLECULAR WEIGHT :
266.57
WISWESSER LINE NOTATION :
T5M CN BUTJ BMR BG FG &GH

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
180 ug/kg
TOXIC EFFECTS :
Behavioral - coma Cardiac - pulse rate Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
AJEMEN American Journal of Emergency Medicine. (WB Saunders, Philadelphia, PA) V.1- 1983- Volume(issue)/page/year: 7,343,1989
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - infant
DOSE/DURATION :
390 ug/kg
TOXIC EFFECTS :
Behavioral - coma Cardiac - pulse rate Vascular - BP elevation not characterized in autonomic section
REFERENCE :
PEDIAU Pediatrics. (American Academy of Pediatrics, P.O. Box 1034, Evanston, IL 60204) V.1- 1948- Volume(issue)/page/year: 72,500,1983
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
126 ug/kg/4W-I
TOXIC EFFECTS :
Gastrointestinal - other changes
REFERENCE :
BMJOAE British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year: 292,174,1986
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
69 ug/kg
TOXIC EFFECTS :
Behavioral - hallucinations, distorted perceptions Vascular - BP lowering not characterized in autonomic section Vascular - pulse pressure increase
REFERENCE :
LANCAO Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- Volume(issue)/page/year: 2,694,1976
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - child
DOSE/DURATION :
70 ug/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Vascular - BP lowering not characterized in autonomic section Lungs, Thorax, or Respiration - other changes
REFERENCE :
AJDCAI American Journal of Diseases of Children. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1-80(3), 1911-50; V.100- 1960- Volume(issue)/page/year: 137,171,1983
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - child
DOSE/DURATION :
100 ug/kg
TOXIC EFFECTS :
Behavioral - irritability Cardiac - EKG changes not diagnostic of specified effects Vascular - BP lowering not characterized in autonomic section
REFERENCE :
CTOXAO Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. Volume(issue)/page/year: 14,271,1979
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
126 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Behavioral - ataxia Skin and Appendages - hair
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 18,366,1987
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
91200 ug/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - chromodacryorrhea Behavioral - tremor Behavioral - ataxia
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 26,4843,1992
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
77 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Behavioral - ataxia Skin and Appendages - hair
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 18,366,1987
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
29 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 16,1038,1966
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
135 mg/kg
TOXIC EFFECTS :
Behavioral - tremor Behavioral - ataxia Skin and Appendages - hair
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 18,366,1987
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
100 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 9,829,1978
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
59 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - excitement Behavioral - ataxia
REFERENCE :
YKKZAJ Yakugaku Zasshi. Journal of Pharmacy. (Nippon Yakugakkai, 2-12-15 Shibuya, Shibuya-ku, Tokyo 150, Japan) No.1- 1881- Volume(issue)/page/year: 95,966,1975
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
17600 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 16,1038,1966
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
30 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
PBPSDY Pharmacological and Biochemical Properties of Drug Substances. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.1- 1977- Volume(issue)/page/year: 1,67,1977
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
10 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 16,1038,1966
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
6 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 16,1038,1966
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Primate - monkey
DOSE/DURATION :
150 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
PBPSDY Pharmacological and Biochemical Properties of Drug Substances. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.1- 1977- Volume(issue)/page/year: 1,67,1977
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
80 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 16,1038,1966
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
30 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 16,1038,1966
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
45 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
PBPSDY Pharmacological and Biochemical Properties of Drug Substances. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.1- 1977- Volume(issue)/page/year: 1,67,1977 ** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
9100 ug/kg/13W-I
TOXIC EFFECTS :
Blood - pigmented or nucleated red blood cells Blood - changes in erythrocyte (RBC) count Blood - changes in leukocyte (WBC) count
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 26,4843,1992 ** REPRODUCTIVE DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
6 mg/kg
SEX/DURATION :
female 30 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Maternal Effects - ovaries, fallopian tubes
REFERENCE :
ZPPLBF Zentralblatt fuer Pharmazie, Pharmakotherapie und Laboratoriums-diagnostik. (VEB Verlag Volk und Gesundheit, Neue Gruenstr. 18, 102 Berlin, Ger. Dem. Rep.) V.109- 1970- Volume(issue)/page/year: 114,251,1975
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
5 ug/kg
SEX/DURATION :
female 1 day(s) after conception
TOXIC EFFECTS :
Reproductive - Maternal Effects - other effects Reproductive - Effects on Embryo or Fetus - other effects to embryo
REFERENCE :
ANESAV Anesthesiology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1940- Volume(issue)/page/year: 67,A449,1987
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
7500 ng/kg
SEX/DURATION :
female 16 week(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - cardiovascular (circulatory) system
REFERENCE :
AJOGAH American Journal of Obstetrics and Gynecology. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1920- Volume(issue)/page/year: 160,471,1989
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Unreported
DOSE :
5 ug/kg
SEX/DURATION :
female 1 day(s) after conception
TOXIC EFFECTS :
Reproductive - Maternal Effects - other effects Reproductive - Effects on Embryo or Fetus - other effects to embryo
REFERENCE :
ANESAV Anesthesiology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1940- Volume(issue)/page/year: 67,A448,1987
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
2080 ug/kg
SEX/DURATION :
female 8-20 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
REFERENCE :
TJADAB Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968- Volume(issue)/page/year: 31,10B,1985 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X5327 No. of Facilities: 53 (estimated) No. of Industries: 1 No. of Occupations: 2 No. of Employees: 859 (estimated) No. of Female Employees: 415 (estimated)
生态数据:

通常对水是不危害的,若无政府许可,勿将材料排入周围环境

MSDS 展开↓

  2-(2,6-二氯苯胺基)-2-咪唑啉盐酸盐      修改号码:2    

模块 1. 化学品
    产品名称:      2-(2,6-Dichloroanilino)-2-imidazoline Hydrochloride    
    修改号码:      2    

模块 2. 危险性概述
  GHS分类
     物理性危害        未分类    
     健康危害
    急性毒性(经口)      第3级    
    急性毒性(吸入)      第1级    
     环境危害        未分类    
  GHS标签元素
     图标或危害标志
     信号词        危险    
     危险描述        吞咽会中毒。    
    吸入致命
     防范说明
  [预防]        切勿吸入。    
    只能在室外或通风良好的环境下使用。
    使用本产品时切勿吃东西,喝水或吸烟。
    处理后要彻底清洗双手。
    佩戴防护面具。
  [急救措施]      吸入:将受害者移到新鲜空气处,在呼吸舒适的地方保持休息。立即呼叫解毒中心/医    
    生。
  食入:立即呼叫解毒中心/医生。
  [储存]        存放于通风良好处。保持容器密闭。    
    存放处须加锁。
  [废弃处置]      根据当地政府规定把物品/容器交与工业废弃处理机构。    

模块 3. 成分/组成信息
  单一物质/混和物        单一物质    
  化学名(中文名):      2-(2,6-二氯苯胺基)-2-咪唑啉盐酸盐    
  2-(2,6-二氯苯胺基)-2-咪唑啉盐酸盐      修改号码:2    

模块 3. 成分/组成信息
    百分比:      >98.0%(LC)(T)    
  CAS编码:      4205-91-8    
    俗名:      Clonidine Hydrochloride , 2-(2,6-Dichlorophenylamino)-2-imidazoline    
  Hydrochloride
    分子式:
  C9H9Cl2N3·HCl

模块 4. 急救措施
    吸入:      将受害者移到新鲜空气处,保持呼吸通畅,休息。立即呼叫解毒中心/医生。    
    皮肤接触:      立即去除/脱掉所有被污染的衣物。用水清洗皮肤/淋浴。    
  若皮肤刺激或发生皮疹:求医/就诊。
    眼睛接触:        用水小心清洗几分钟。如果方便,易操作,摘除隐形眼镜。继续清洗。    
  如果眼睛刺激:求医/就诊。
    食入:      立即呼叫解毒中心/医生。漱口。    
    紧急救助者的防护:        救援者需要穿戴个人防护用品,比如橡胶手套和气密性护目镜。    

模块 5. 消防措施
    合适的灭火剂:        干粉,泡沫,雾状水,二氧化碳    
    特殊危险性:        小心,燃烧或高温下可能分解产生毒烟。    
    特定方法:        从上风处灭火,根据周围环境选择合适的灭火方法。    
    非相关人员应该撤离至安全地方。
    周围一旦着火:如果安全,移去可移动容器。
    消防员的特殊防护用具:        灭火时,一定要穿戴个人防护用品。    

模块 6. 泄漏应急处理
    个人防护措施,防护用具,      使用特殊的个人防护用品(自携式呼吸器)。远离溢出物/泄露处并处在上风处。    
    紧急措施:        泄露区应该用安全带等圈起来,控制非相关人员进入。    
    环保措施:        防止进入下水道。    
    控制和清洗的方法和材料:        清扫收集粉尘,封入密闭容器。注意切勿分散。附着物或收集物应该立即根据合适的    
    法律法规处置。

模块 7. 操作处置与储存
    处理
    技术措施:        在通风良好处进行处理。穿戴合适的防护用具。防止粉尘扩散。处理后彻底清洗双手    
    和脸。
    注意事项:        如果可能,使用封闭系统。如果粉尘或浮质产生,使用局部排气。    
    操作处置注意事项:        避免接触皮肤、眼睛和衣物。    
    贮存
    储存条件:        保持容器密闭。存放于凉爽、阴暗、通风良好处。    
    存放处须加锁。
    远离不相容的材料比如氧化剂存放。
    包装材料:        依据法律。    

模块 8. 接触控制和个体防护
    工程控制:        尽可能安装封闭体系或局部排风系统。同时安装淋浴器和洗眼器。    
    个人防护用品
     呼吸系统防护:      防尘面具,自携式呼吸器(SCBA),供气呼吸器等。使用通过政府标准的呼吸器。依    
    据当地和政府法规。
     手部防护:        防渗手套。    
     眼睛防护:        护目镜。如果情况需要,佩戴面具。    
  2-(2,6-二氯苯胺基)-2-咪唑啉盐酸盐      修改号码:2    

模块 8. 接触控制和个体防护
     皮肤和身体防护:        防渗防护服。如果情况需要,穿戴防护靴。    

模块 9. 理化特性
  外形(20°C):        固体    
    外观:      晶体-粉末    
    颜色:        白色类白色    
    气味:        无资料    
  pH:        无数据资料    
    熔点:      312°C    
  沸点/沸程        无资料    
    闪点:        无资料    
    爆炸特性
     爆炸下限:        无资料    
     爆炸上限:        无资料    
    密度:        无资料    
    溶解度:        溶于: 乙醇 水    
    微溶于: 氯仿
    不溶于: 醚

模块 10. 稳定性和反应性
    稳定性:        一般情况下稳定。    
    反应性:        未报道特殊反应性。    
    避免接触的条件:        光敏    
    须避免接触的物质        氧化剂    
  危险的分解产物:      一氧化碳, 二氧化碳, 氮氧化物 (NOx), 氯化氢    

模块 11. 毒理学信息
    急性毒性:      ipr-rat LD50:91.2 mg/kg    
  orl-rat LD50:126 mg/kg
    对皮肤腐蚀或刺激:        无资料    
    对眼睛严重损害或刺激:        无资料    
    生殖细胞变异原性:        无资料    
    致癌性:
  IARC =        无资料    
  NTP =        无资料    
    生殖毒性:        无资料    
  RTECS 号码:      NJ2490000    

模块 12. 生态学信息
    生态毒性:
    鱼类:        无资料    
    甲壳类:        无资料    
    藻类:        无资料    
  残留性 / 降解性:        无资料    
  潜在生物累积 (BCF):        无资料    
    土壤中移动性
   log水分配系数:        无资料    
   土壤吸收系数 (Koc):        无资料    
     亨利定律        无资料    
  constant(PaM3/mol):
  2-(2,6-二氯苯胺基)-2-咪唑啉盐酸盐      修改号码:2    

模块 13. 废弃处置
    如果可能,回收处理。请咨询当地管理部门。建议在可燃溶剂中溶解混合,在装有后燃和洗涤装置的化学焚烧炉中
    焚烧。废弃处置时请遵守国家、地区和当地的所有法规。

模块 14. 运输信息
    联合国分类:      第1项 毒害品。    
  UN编号:      2811    
    正式运输名称:      有毒固体, 有机物, 不另作详细说明    
    包装等级:      I    

模块 15. 法规信息
  《危险化学品安全管理条例》(2002年1月26日国务院发布): 针对危险化学品的安全使用、生产、储存、运输、装
    卸等方面均作了相应的规定。


模块16 - 其他信息
N/A

海关数据查看详细

中国海关编码:2933290090

概述:
2933290090. 其他结构含非稠合咪唑环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素:
品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期
摘要/Summary:
2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

分子结构与计算化学数据展开↓

计算化学数据


1、   氢键供体数量:3

2、   氢键受体数量:3

3、   可旋转化学键数量:2

4、   互变异构体数量:2

5、   拓扑分子极性表面积(TPSA):36.4

6、   重原子数量:15

7、   表面电荷:0

8、   复杂度:222

9、   同位素原子数量:0

10、   确定原子立构中心数量:0

11、   不确定原子立构中心数量:0

12、   确定化学键立构中心数量:0

13、   不确定化学键立构中心数量:0

14、   共价键单元数量:2

上下游相关产品

上游产品

更多
  • 55150-38-4

    1-phenoxyacetyl-imidazolidin-2-one

  • 608-31-1

    2,6-二氯苯胺

  • 5391-39-9

    N-乙酰基-2-咪唑烷酮

  • 825-43-4

    2-oxo-imidazolidine-1-carboxylic acid ethyl ester

  • 120-93-4

    2-咪唑烷酮

立即下载安装“化学加”APP
专业、功能强大,随时调用更加方便